Chad M. House , Huong Dang , Katie A. Moriarty , William B. Nelson
{"title":"Prevalence and impact of cognitive impairment assessed by Mini-Cog in hospitalized cardiac rehabilitation referrals","authors":"Chad M. House , Huong Dang , Katie A. Moriarty , William B. Nelson","doi":"10.1016/j.rccl.2023.06.001","DOIUrl":"10.1016/j.rccl.2023.06.001","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Evaluate patients referred for cardiac rehabilitation to determine the prevalence of cognitive impairment (CI) and compare readmission rates and mortality for those with and without CI.</p></div><div><h3>Methods</h3><p>Patients were retrospectively divided into cohort A (Mini-Cog completed) and cohort B (Mini-Cog not completed). Cohort A was then divided into A<sub>1</sub> (Mini-Cog positive for CI) and A<sub>2</sub> (Mini-Cog negative for CI).</p></div><div><h3>Results</h3><p>Of 1440 patients, 986 (68%) completed the Mini-Cog (cohort A) and 454 (32%) patients did not (cohort B). Within cohort A, 46 (4.7%) had a positive Mini-Cog (cohort A<sub>1</sub>) and 940 (95.3%) had a negative Mini-Cog (cohort A<sub>2</sub>). Cohort A<sub>1</sub> had significantly higher rates of all-cause readmission compared with cohorts A<sub>2</sub> and B (63% vs 44% and 47%; <em>P</em> <!-->=<!--> <em>.02</em>), and significantly higher mortality (28% vs 9% vs 15%; <em>P</em> <!--><<!--> <em>.001</em>), but was also significantly older, with more co-morbidities. After accounting for demographic and co-morbidity differences between cohorts A<sub>1</sub> and A<sub>2</sub><span><span> using propensity score matching and Cox </span>proportional hazards model, cohort A</span><sub>1</sub> had significantly increased rates of the composite outcome of readmission and/or death at 3-months (<em>P</em> <!-->=<!--> <em>.002</em>).</p></div><div><h3>Conclusions</h3><p>Poor performance on the Mini-Cog identified an older group of phase I cardiac rehabilitation patients that had significantly increased rates of the combined end-point of readmission plus death.</p></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"58 4","pages":"Pages 272-280"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45486669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eduardo Arana-Rueda, Manuel Frutos-López, Alonso Pedrote
{"title":"Utilidad de los fármacos antiarrítmicos tras la ablación de la fibrilación auricular","authors":"Eduardo Arana-Rueda, Manuel Frutos-López, Alonso Pedrote","doi":"10.1016/j.rccl.2023.07.006","DOIUrl":"10.1016/j.rccl.2023.07.006","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"58 4","pages":"Pages 257-259"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46717060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alberto Esteban-Fernández , Manuel Méndez-Bailón , Mónica Pérez-Serrano , Teresa Morales Martínez , Julia Gómez Diego , Ángel Nieto , María Molina , Julián Pérez Villacastín , Inmaculada Fernández Rozas , Ramón Bover
{"title":"Ferric carboxymaltose for patients with heart failure in all-range ejection fraction","authors":"Alberto Esteban-Fernández , Manuel Méndez-Bailón , Mónica Pérez-Serrano , Teresa Morales Martínez , Julia Gómez Diego , Ángel Nieto , María Molina , Julián Pérez Villacastín , Inmaculada Fernández Rozas , Ramón Bover","doi":"10.1016/j.rccl.2023.06.002","DOIUrl":"10.1016/j.rccl.2023.06.002","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Iron deficiency (ID) is common in heart failure (HF) patients and is linked to exercise impairment, worse quality of life<span>, and HF hospitalisation. Clinical practice guidelines recommend checking and correcting ID with ferric carboxymaltose<span> (FCM). However, there is a lack of evidence in patients<span> with left ventricular ejection fraction (LVEF) >40%.</span></span></span></p></div><div><h3>Methods</h3><p>We included all HF outpatients treated with FCM after ID diagnosis (ferritin <100<!--> <span>ng/mL or ferritin 100–299</span> <span>ng/mL and transferrin saturation <20%). We analysed clinical and analytical parameters before FCM administration and at 3 months according to LVEF: preserved (>50%), mildly reduced (41–49%), and reduced (<40%).</span></p></div><div><h3>Results</h3><p>We included 235 patients (51.5% female) aged 73.5<!--> <!-->±<!--> <!-->10.7 years. Ninety-six patients have reduced LVEF (40.8%), 41 mildly reduced (17.4%), and 98 preserved (41.7%). Patients with preserved LVEF have more anaemia (42.6% vs 26.8% vs 52.6%; <em>P</em> <!-->=<!--> <!-->.02). Less than 50% of patients received the correct dose of FCM, especially patients with preserved LVEF (<em>P</em> <!-->=<!--> <!-->.004). One patient (0.4%) presented a local exanthema with no other adverse effects. At 3 months, all analytical parameters significantly improved, except haemoglobin (12.9 vs 13.0<!--> <!-->mg/dL; <em>P</em> <!-->=<!--> <span>.95) and natriuretic peptides (3261 vs 3471</span> <!-->pg/mL; <em>P</em> <!-->=<!--> <!-->.56) in mildly reduced LVEF patients. The functional class did not improve in preserved LVEF patients, but it did in the rest.</p></div><div><h3>Conclusions</h3><p>FCM is safe and effective in correcting ID in HF patients regardless of LVEF. Natriuretic peptides are reduced in all patients except those with mildly reduced LVEF. Functional class improvement is less likely in patients with preserved LVEF.</p></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"58 4","pages":"Pages 281-288"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46466532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pablo Martín-Marín, Antonio Delgado-Ariza, Alba Abril Molina, Jaime Nevado-Portero
{"title":"Serie de casos: síndrome de Kounis, una entidad infradiagnosticada","authors":"Pablo Martín-Marín, Antonio Delgado-Ariza, Alba Abril Molina, Jaime Nevado-Portero","doi":"10.1016/j.rccl.2023.05.005","DOIUrl":"10.1016/j.rccl.2023.05.005","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"58 4","pages":"Pages 329-331"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44309947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abordaje de la hipertensión pulmonar en España. ¿Cuál es nuestra guía?","authors":"Manuel Gómez Bueno , Javier Segovia Cubero","doi":"10.1016/j.rccl.2023.07.008","DOIUrl":"10.1016/j.rccl.2023.07.008","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"58 4","pages":"Pages 253-256"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42332699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Javier Torres Llergo, Miguel Puentes Chiachío, José María Segura Aumente, Juan Carlos Fernández Guerrero, María Rosa Fernández Olmo
{"title":"Experiencia clínica y seguridad de la terapia fundacional en el paciente hospitalizado por insuficiencia cardiaca","authors":"Javier Torres Llergo, Miguel Puentes Chiachío, José María Segura Aumente, Juan Carlos Fernández Guerrero, María Rosa Fernández Olmo","doi":"10.1016/j.rccl.2023.03.008","DOIUrl":"10.1016/j.rccl.2023.03.008","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"58 4","pages":"Pages 324-327"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42435428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}